Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, M.
Right arrow Articles by Heimans, J.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, M.
Right arrow Articles by Heimans, J.J.
Related Collections
Right arrow All Oncology
Right arrow Primary brain tumor
Right arrow Assessment of cognitive disorders/dementia
NEUROLOGY 2003;61:1796-1798
© 2003 American Academy of Neurology
Brief Communications

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma

M. Klein, PhD, T.J. Postma, MD PhD, M.J.B. Taphoorn, MD PhD, N.K. Aaronson, PhD, W.P. Vandertop, MD PhD, M. Muller, MSc, H.M. van der Ploeg, PhD and J.J. Heimans, MD PhD

From the Departments of Medical Psychology (Drs. Klein and van der Ploeg), Neurology (Drs. Postma and Heimans), and Neurosurgery (Dr. Vandertop), VU University Medical Center, Amsterdam; Department of Neurology (Dr. Taphoorn), University Medical Center Utrecht; and Division of Psychosocial Research & Epidemiology (Drs. Aaronson and Muller), The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Address correspondence and reprint requests to Dr. M. Klein, VU University Medical Center, Department of Medical Psychology, Van der Boechorststraat 7, 1081 BT Amsterdam, the Netherlands; e-mail: m.klein{at}vumc.nl

The authors studied cognitive functioning as a potential predictor of survival in 68 newly diagnosed patients with high-grade glioma. In a combined Cox proportional hazards model, the influence of tumor, treatment, and patient characteristics, including cognitive functioning, was studied. Older age and higher tumor grade were associated with poorer survival. Although cognitive impairment was not found to be an independent prognostic factor for the entire sample, it was associated with significantly poorer survival among older patients with World Health Organization grade IV gliomas. Assessment of cognitive functioning in these patients may improve clinical decision making and thus quality of treatment.

Received June 12, 2003. Accepted in final form August 20, 2003.




This article has been cited by other articles:


Home page
 DiabetesHome page
E. van Duinkerken, M. Klein, N. S.M. Schoonenboom, R. P.L.M. Hoogma, A. C. Moll, F. J. Snoek, C. J. Stam, and M. Diamant
Functional Brain Connectivity and Neurocognitive Functioning in Patients With Long-Standing Type 1 Diabetes With and Without Microvascular Complications: A Magnetoencephalography Study
Diabetes, October 1, 2009; 58(10): 2335 - 2343.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
R. Liu, M. Page, K. Solheim, S. Fox, and S. M. Chang
Quality of life in adults with brain tumors: Current knowledge and future directions
Neuro Oncology, June 1, 2009; 11(3): 330 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
J.-x. Cheng, X. Zhang, and B.-L. Liu
Health-related quality of life in patients with high-grade glioma
Neuro Oncology, February 1, 2009; 11(1): 41 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
I. Bosma, J. C. Reijneveld, L. Douw, M. J. Vos, T. J. Postma, N. K. Aaronson, M. Muller, W. P. Vandertop, B. J. Slotman, M. J. B. Taphoorn, et al.
Health-related quality of life of long-term high-grade glioma survivors
Neuro Oncology, February 1, 2009; 11(1): 51 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
I. Bosma, L. Douw, F. Bartolomei, J. J. Heimans, B. W. van Dijk, T. J. Postma, C. J. Stam, J. C. Reijneveld, and M. Klein
Synchronized brain activity and neurocognitive function in patients with low-grade glioma: A magnetoencephalography study
Neuro Oncology, October 1, 2008; 10(5): 734 - 744.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. E.L. Mauer, M. J.B. Taphoorn, A. Bottomley, C. Coens, F. Efficace, M. Sanson, A. A. Brandes, C. C.D. van der Rijt, H. J.J.A. Bernsen, M. Frenay, et al.
Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study
J. Clin. Oncol., December 20, 2007; 25(36): 5731 - 5737.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
I. Bosma, M. J. Vos, J. J. Heimans, M. J.B. Taphoorn, N. K. Aaronson, T. J. Postma, H. M. van der Ploeg, M. Muller, W. P. Vandertop, Ben. J. Slotman, et al.
The course of neurocognitive functioning in high-grade glioma patients
Neuro Oncology, January 1, 2007; 9(1): 53 - 62.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. McCarter, W. Furlong, A. C. Whitton, D. Feeny, S. DePauw, A. R. Willan, and R. D. Barr
Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors
J. Clin. Oncol., August 1, 2006; 24(22): 3636 - 3643.
[Abstract] [Full Text] [PDF]